108 related articles for article (PubMed ID: 1631798)
21. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
22. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
Kole KL; Gyetko MR; Simpson RU; Sitrin RG
Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
[TBL] [Abstract][Full Text] [Related]
23. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
24. Alveolar epithelial cell plasminogen activator. Characterization and regulation.
Marshall BC; Sageser DS; Rao NV; Emi M; Hoidal JR
J Biol Chem; 1990 May; 265(14):8198-204. PubMed ID: 2110565
[TBL] [Abstract][Full Text] [Related]
25. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
Ramsby ML; Kreutzer DL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
[TBL] [Abstract][Full Text] [Related]
27. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
Hart DA; Smith R
Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
[TBL] [Abstract][Full Text] [Related]
28. Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity.
Hansen SH; Behrendt N; Danø K; Kristensen P
Exp Cell Res; 1990 Apr; 187(2):255-62. PubMed ID: 2156717
[TBL] [Abstract][Full Text] [Related]
29. [Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line].
Niiya K
Rinsho Ketsueki; 1991 May; 32(5):490-6. PubMed ID: 1870266
[TBL] [Abstract][Full Text] [Related]
30. Phorbol-ester-stimulated human lymphoid cell lines produce a plasminogen activator modulator inducing cell-bound urokinase-type plasminogen activator in malignant tumor cell lines.
Osada H; Kono T; Miwa K; Yamada C
Int J Cancer; 1996 Jan; 65(2):178-85. PubMed ID: 8567114
[TBL] [Abstract][Full Text] [Related]
31. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.
Bosma PJ; Kooistra T
J Biol Chem; 1991 Sep; 266(27):17845-9. PubMed ID: 1655729
[TBL] [Abstract][Full Text] [Related]
32. Cells of the human myelomonocytic line RC-2A synthesize tissue factor-like procoagulant and urokinase-type plasminogen activator.
Karhumäki E; Saravo L; Helin H
J Leukoc Biol; 1987 Jul; 42(1):36-42. PubMed ID: 3298513
[TBL] [Abstract][Full Text] [Related]
33. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay.
Lund LR; Georg B; Nielsen LS; Mayer M; Danø K; Andreasen PA
Mol Cell Endocrinol; 1988 Nov; 60(1):43-53. PubMed ID: 3265112
[TBL] [Abstract][Full Text] [Related]
35. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.
Alving BM; Krishnamurti C; Liu YP; Lucas DL; Wright DG
Thromb Res; 1988 Jul; 51(2):175-85. PubMed ID: 3142093
[TBL] [Abstract][Full Text] [Related]
36. Urokinase synthesis and binding by glomerular epithelial cells in culture.
Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
[TBL] [Abstract][Full Text] [Related]
37. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
[TBL] [Abstract][Full Text] [Related]
39. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
Kiguchi T; Niiya K; Shibakura M; Miyazono T; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Nakata Y; Harada M
Int J Cancer; 2001 Sep; 93(6):792-7. PubMed ID: 11519039
[TBL] [Abstract][Full Text] [Related]
40. Tissue plasminogen activator-induced secretion of type-1 plasminogen activator inhibitor in cultured human fibroblasts.
Reilly TM; Greenplate G; Timmermans PB
Thromb Res; 1989 Sep; 55(5):619-25. PubMed ID: 2510361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]